Introduction: Atrial fibrillation (AF) is one of the leading causes of ischaemic stroke. However, screening for AF is often time-consuming in clinical practice. Therefore, the determination of an appropriate marker to detect the presence of AF would improve the diagnostic process.
View Article and Find Full Text PDFBackground: Cryoballoon ablation for the treatment of patients with atrial fibrillation (AF) has been utilized in Europe for >15 years.
Objectives: Report patient and procedural characteristics that influence the safety of cryoablation for the treatment of AF.
Methods: Patients enrolled in the prospective, multicenter Cryo AF Global Registry were treated at 38 European centers.
Bratisl Lek Listy
February 2021
Objectives And Background: Studies assessing the unicentric and prospective comparison of efficacy of cryoballoon pulmonary vein isolation in idiopathic and non-idiopathic atrial fibrillation (AF) patients are missing. The aim of this study was to compare a single procedural outcome in these subgroups of AF patients.
Methods: A total of 208 patients with drug resistant AF were included in this study.
Bratisl Lek Listy
December 2020
Objective: To describe the initial experience with Amplatzer Amulet in left atrial appendage occlusion in Slovakia. To evaluate procedural efficacy and safety.
Background: Atrial fibrillation increases the risk of stroke.
Background: Cardiac troponin I (cTnI) is a valuable prognostic biomarker in patients with chronic heart failure (CHF). However, the prognostic importance of cTnI in patients who received cardiac resynchronisation therapy (CRT) remains unknown. The aim of this prospective study was to determine the prognostic value of high-sensitive cTnI (hs-cTnI) in CHF patients receiving CRT.
View Article and Find Full Text PDF